Nivolumab improves survival of kidney cancer patients at three years
Updated results from the phase 3 CheckMate-025 study, presented at [...]
Updated results from the phase 3 CheckMate-025 study, presented at [...]
AVEO Oncology and EUSA Pharma have announced promising results from [...]
A retrospective study has proven the effectiveness and tolerability of [...]
The following is an interview with Dr Eric Jonasch, Professor [...]
Researchers from France and the USA have shown that the [...]
A recent study by researchers from the Gustave Roussy Cancer Campus in [...]
The Telegraph has reported on comments made by Jeremy Hunt MP, [...]